Skip to main content

Enhanced platelet IIb/IIIa inhibition with eptifibatide via high-dose, double-bolus dosing: Final results of the PRIDE study

Publication ,  Journal Article
Gilchrist, IC; Thel, MC; Joseph, D; Zimmerman, HE; Jennings, LK; Kleiman, NS; Kerelakes, DJ; Talley, JD; O'Brien, MA; Lorenz, T; Tcheng, JE
Published in: CIRCULATION
October 27, 1998

Duke Scholars

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

October 27, 1998

Volume

98

Issue

17

Start / End Page

844 / 845

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gilchrist, I. C., Thel, M. C., Joseph, D., Zimmerman, H. E., Jennings, L. K., Kleiman, N. S., … Tcheng, J. E. (1998). Enhanced platelet IIb/IIIa inhibition with eptifibatide via high-dose, double-bolus dosing: Final results of the PRIDE study. CIRCULATION, 98(17), 844–845.
Gilchrist, I. C., M. C. Thel, D. Joseph, H. E. Zimmerman, L. K. Jennings, N. S. Kleiman, D. J. Kerelakes, et al. “Enhanced platelet IIb/IIIa inhibition with eptifibatide via high-dose, double-bolus dosing: Final results of the PRIDE study.” CIRCULATION 98, no. 17 (October 27, 1998): 844–45.
Gilchrist IC, Thel MC, Joseph D, Zimmerman HE, Jennings LK, Kleiman NS, et al. Enhanced platelet IIb/IIIa inhibition with eptifibatide via high-dose, double-bolus dosing: Final results of the PRIDE study. CIRCULATION. 1998 Oct 27;98(17):844–5.
Gilchrist, I. C., et al. “Enhanced platelet IIb/IIIa inhibition with eptifibatide via high-dose, double-bolus dosing: Final results of the PRIDE study.” CIRCULATION, vol. 98, no. 17, LIPPINCOTT WILLIAMS & WILKINS, Oct. 1998, pp. 844–45.
Gilchrist IC, Thel MC, Joseph D, Zimmerman HE, Jennings LK, Kleiman NS, Kerelakes DJ, Talley JD, O’Brien MA, Lorenz T, Tcheng JE. Enhanced platelet IIb/IIIa inhibition with eptifibatide via high-dose, double-bolus dosing: Final results of the PRIDE study. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 1998 Oct 27;98(17):844–845.

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

October 27, 1998

Volume

98

Issue

17

Start / End Page

844 / 845

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology